Previous research has also revealed aberrantly high levels of CYP24A1 in multiple kinds of cancer cells, including ovarian cancer, breast cancer, thyroid cancer, and glioma cells (38–41), thereby making them resistant to 1α,25(OH)2D3. This evidence concerns the gene CYP24A1 and thyroid gland carcinoma.